intermittent fasting on glp-1 + Injections: Smart or Dangerous? | Blog intermittent fasting vs glp 1
Description
As researchers decipher how GLP-1s affect mental health, experts worry access is outpacing the scientific investigation
The ADA now recommends GLP1 RAs with proven benefit to slow CKD progression and reduce CV risk in people with type 2 diabetes
In findings from an analysis of Medicare data published in Diabetes Care, the incidence rate of GLP-1 receptor agonist or SGLT2 inhibitor initiation was 0.34 per 100
Therapeutic errors accounted for 91% of exposures
Help your clients navigate the growing use of GLP-1 and GIP medications with confidence and professionalism
